GlassScriptPhysician profile
Asif M Chaudhry
NPI 1679774152
$8,829.89
in general payments reported to CMS, 2019-2025
26 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
See the full distribution for Pain Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,290 · 2020: $1,054 · 2021: $1,186 · 2022: $1,707 · 2023: $324 · 2024: $848 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572 · Travel and Lodging: $21.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,571.70 |
| Travel and Lodging | $21.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,510.98 | 2019-2024 | Senza |
| Medtronic, INC. | $3,167.10 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Medtronic USA, INC. | $909.78 | 2019-2020 | |
| Boston Scientific Corporation | $149.16 | 2019 | |
| Vertos Medical, INC. | $132.74 | 2022 | |
| Si-Bone, INC. | $98.32 | 2019-2020 | |
| Abbott Laboratories | $90.10 | 2021 | |
| Collegium Pharmaceutical, INC. | $87.74 | 2019-2020 | |
| Grt US Holding, INC. | $71.63 | 2020-2021 | |
| Medinc of Texas | $68.50 | 2024 | |
| Depuy Synthes Sales INC. | $68.12 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.11 | 2019-2022 | |
| Vertiflex, INC. | $59.34 | 2019 | |
| Painteq LLC | $59.13 | 2023-2024 | Painteq |
| Zyla Life Sciences, INC. | $40.75 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $38.84 | 2021 | |
| Ermi LLC | $35.34 | 2022 | |
| Amgen INC. | $29.70 | 2019 | |
| Spr Therapeutics, INC | $27.57 | 2023 | Sprint Pns System |
| Amniox Medical, INC. | $24.48 | 2020 | |
| Baudax Bio INC. | $22.52 | 2020 | |
| Foundation Fusion Solutions, LLC | $19.84 | 2021 | |
| Pfizer INC. | $15.12 | 2019 | |
| Fidia Pharma USA INC. | $13.33 | 2022 | |
| Stimwave Technologies Incorporated | $12.02 | 2019 | |
| Arteriocyte Medical Systems, INC. | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.